<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/70"/><api:result><api:object category="publication" id="70" last-affected-when="2024-03-16T18:09:55.9+00:00" last-modified-when="2024-03-16T18:09:55.9+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/70" created-when="2010-05-17T13:46:10.48+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2001-12-25</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1387365" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1046/j.1365-2141.1999.01193.x" last-modified-when="2023-11-04T01:35:50.67+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:p&gt;Interleukin‐1β (IL‐1β) and tumour necrosis factor‐α (TNF‐α) are potent bone resorbing cytokines that may contribute to the development of the osteolytic bone disease observed in patients with multiple myeloma (MM). Although these factors have been identified in cultures of bone marrow mononuclear cells isolated from patients, the identity of the cells responsible for producing IL‐1β and TNFα remains unclear. Using a sensitive dual‐colour fluorescence &lt;jats:italic&gt;in situ&lt;/jats:italic&gt; hybridization (FISH) technique and a two‐colour immunofluorescence method we have investigated the expression of the mRNA and protein, for IL‐1β and TNFα, by individual bone marrow plasma cells from patients with MM and monoclonal gammopathy of undetermined significance (MGUS). The mRNA for IL‐1β and TNFα was identified in all cells expressing the immunoglobulin light chain from all patients with MM and MGUS. However, the IL‐1β protein could not be detected in cytoplasmic light chain positive cells in any of the patients examined. In contrast, the TNFα protein was detected in clonal plasma cells from patients with both MM and MGUS. Interestingly, the IL‐1β and TNFα mRNA and proteins were readily detected within a small proportion of the non‐plasma cells from patients with both MM and MGUS. These data suggest that myeloma cells &lt;jats:italic&gt;in vivo&lt;/jats:italic&gt; are able to produce TNFα but not IL‐1β. In addition, a small proportion of accessory cells are likely to be able to contribute to the production of both IL‐1β and TNFα.&lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sati</api:last-name><api:initials>HIA</api:initials><api:first-names>Hamdi IA</api:first-names><api:separate-first-names><api:first-name>Hamdi</api:first-name><api:first-name>I</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Greaves</api:last-name><api:initials>M</api:initials><api:first-names>Mike</api:first-names><api:separate-first-names><api:first-name>Mike</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>Jane F</api:first-names><api:separate-first-names><api:first-name>Jane</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>R Graham G</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>Graham</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>Peter I</api:first-names><api:separate-first-names><api:first-name>Peter</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.1999.01193.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.1999.01193.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.1999.01193.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2141</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Haematology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>25</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>350</api:begin-page><api:end-page>357</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1046/j.1365-2141.1999.01193.x</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>28</api:day><api:month>10</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of interleukin‐1β and tumour necrosis factor‐α in plasma cells from patients with multiple myeloma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" id="94165" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032589103" last-modified-when="2023-10-11T07:41:53.697+01:00"><api:citation-count>82</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) are potent bone resorbing cytokines that may contribute to the development of the osteolytic bone disease observed in patients with multiple myeloma (MM). Although these factors have been identified in cultures of bone marrow mononuclear cells isolated from patients, the identity of the cells responsible for producing IL-1β and TNFα remains unclear. Using a sensitive dual-colour fluorescence in situ hybridization (FISH) technique and a two- colour immunofluorescence method we have investigated the expression of the mRNA and protein, for IL-1β and TNFα, by individual bone marrow plasma cells from patients with MM and monoclonal gammopathy of undetermined significance (MGUS). The mRNA for IL-1β and TNFα was identified in all cells expressing the immunoglobulin light chain from all patients with MM and MGUS. However, the IL-1β protein could not be detected in cytoplasmic light chain positive cells in any of the patients examined. In contrast, the TNFα protein was detected in clonal plasma cells from patients with both MM and MGUS. Interestingly, the IL-1β and TNFα mRNA and proteins were readily detected within a small proportion of the non-plasma cells from patients with both MM and MGUS. These data suggest that myeloma cells in vivo are able to produce TNFα but not IL-1β. In addition, a small proportion of accessory cells are likely to be able to contribute to the production of both IL-1β and TNFα.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sati</api:last-name><api:initials>HIA</api:initials><api:first-names>HIA</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>I</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603097812</api:identifier></api:identifiers></api:person><api:person><api:last-name>Greaves</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Aberdeen</api:line><api:line type="city">Aberdeen</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7402534565</api:identifier></api:identifiers></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London School of Medicine</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005558171</api:identifier></api:identifiers></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>RGG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7403934359</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">26635094100</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.1999.01193.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.1999.01193.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.1999.01193.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10050719</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Haematology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>350</api:begin-page><api:end-page>357</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of interleukin-1β and tumour necrosis factor-α in plasma cells from patients with multiple myeloma</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" id="70" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10050719" last-modified-when="2020-04-29T00:34:28.857+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Interleukin-1beta(IL-1beta) and tumour necrosis factor-alpha (TNF-alpha) are potent bone resorbing cytokines that may contribute to the development of the osteolytic bone disease observed in patients with multiple myeloma (MM). Although these factors have been identified in cultures of bone marrow mononuclear cells isolated from patients, the identity of the cells responsible for producing IL-1beta and TNFalpha remains unclear. Using a sensitive dual-colour fluorescence in situ hybridization (FISH) technique and a two-colour immunofluorescence method we have investigated the expression of the mRNA and protein, for IL-1beta and TNFalpha, by individual bone marrow plasma cells from patients with MM and monoclonal gammopathy of undetermined significance (MGUS). The mRNA for IL-1beta and TNFalpha was identified in all cells expressing the immunoglobulin light chain from all patients with MM and MGUS. However, the IL-1beta protein could not be detected in cytoplasmic light chain positive cells in any of the patients examined. In contrast, the TNFalpha protein was detected in clonal plasma cells from patients with both MM and MGUS. Interestingly, the IL-1beta and TNFalpha mRNA and proteins were readily detected within a small proportion of the non-plasma cells from patients with both MM and MGUS. These data suggest that myeloma cells in vivo are able to produce TNFalpha but not IL-1beta. In addition, a small proportion of accessory cells are likely to be able to contribute to the production of both ILbeta and TNFalpha.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sati</api:last-name><api:initials>HI</api:initials><api:first-names>HI</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Biochemical and Musculoskeletal Medicine, University of Sheffield Medical School.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Greaves</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RG</api:initials><api:first-names>RG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10050719</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.1999.01193.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.1999.01193.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.1999.01193.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Haematol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Fluorescent Antibody Technique</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin-1</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Paraproteinemias</api:keyword><api:keyword scheme="mesh">Plasma Cells</api:keyword><api:keyword scheme="mesh">RNA, Messenger</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>350</api:begin-page><api:end-page>357</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>30</api:day><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" id="872985" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10050719" last-modified-when="2023-11-08T00:35:54.027+00:00"><api:citation-count>46</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Interleukin-1beta(IL-1beta) and tumour necrosis factor-alpha (TNF-alpha) are potent bone resorbing cytokines that may contribute to the development of the osteolytic bone disease observed in patients with multiple myeloma (MM). Although these factors have been identified in cultures of bone marrow mononuclear cells isolated from patients, the identity of the cells responsible for producing IL-1beta and TNFalpha remains unclear. Using a sensitive dual-colour fluorescence in situ hybridization (FISH) technique and a two-colour immunofluorescence method we have investigated the expression of the mRNA and protein, for IL-1beta and TNFalpha, by individual bone marrow plasma cells from patients with MM and monoclonal gammopathy of undetermined significance (MGUS). The mRNA for IL-1beta and TNFalpha was identified in all cells expressing the immunoglobulin light chain from all patients with MM and MGUS. However, the IL-1beta protein could not be detected in cytoplasmic light chain positive cells in any of the patients examined. In contrast, the TNFalpha protein was detected in clonal plasma cells from patients with both MM and MGUS. Interestingly, the IL-1beta and TNFalpha mRNA and proteins were readily detected within a small proportion of the non-plasma cells from patients with both MM and MGUS. These data suggest that myeloma cells in vivo are able to produce TNFalpha but not IL-1beta. In addition, a small proportion of accessory cells are likely to be able to contribute to the production of both ILbeta and TNFalpha.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Biochemical and Musculoskeletal Medicine, University of Sheffield Medical School.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sati</api:last-name><api:initials>HI</api:initials><api:first-names>HI</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Greaves</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RG</api:initials><api:first-names>RG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-4136-1828</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-7102-2413</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.1999.01193.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.1999.01193.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.1999.01193.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2141</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10050719</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of haematology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Plasma Cells</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Paraproteinemias</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh">RNA, Messenger</api:keyword><api:keyword scheme="mesh">Interleukin-1</api:keyword><api:keyword scheme="mesh">Fluorescent Antibody Technique</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>350</api:begin-page><api:end-page>357</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>2</api:day><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" id="2710052" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1016604823" last-modified-when="2024-03-16T18:09:55.91+00:00"><api:citation-count>83</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>3</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sati</api:last-name><api:initials>HIA</api:initials><api:first-names>Hamdi IA</api:first-names><api:separate-first-names><api:first-name>Hamdi</api:first-name><api:first-name>I</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0746746604.32</api:identifier></api:identifiers></api:person><api:person><api:last-name>Greaves</api:last-name><api:initials>M</api:initials><api:first-names>Mike</api:first-names><api:separate-first-names><api:first-name>Mike</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Aberdeen</api:line><api:line type="city">Aberdeen</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01063175204.59</api:identifier></api:identifiers></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>Jane F</api:first-names><api:separate-first-names><api:first-name>Jane</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0753003365.31</api:identifier></api:identifiers></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>R Graham G</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>Graham</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.010061341002.17</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>Peter I</api:first-names><api:separate-first-names><api:first-name>Peter</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0756766474.08</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.1999.01193.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.1999.01193.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.1999.01193.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10050719</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Haematology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3201 Cardiovascular Medicine and Haematology</api:keyword><api:keyword scheme="for-2020">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Hematology</api:keyword><api:keyword scheme="rcdc">Rare Diseases</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Fluorescent Antibody Technique</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin-1</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Paraproteinemias</api:keyword><api:keyword scheme="mesh">Plasma Cells</api:keyword><api:keyword scheme="mesh">RNA, Messenger</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>25</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>350</api:begin-page><api:end-page>357</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>1.56</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of interleukin‐1β and tumour necrosis factor‐α in plasma cells from patients with multiple myeloma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" id="239704" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000078676100022" last-modified-when="2024-03-14T05:31:57.19+00:00"><api:citation-count>74</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sati</api:last-name><api:initials>HIA</api:initials><api:first-names>HIA</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>I</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Greaves</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>RGG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000078676100022&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.1999.01193.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.1999.01193.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.1999.01193.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2141</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">168DN</api:identifier><api:identifier scheme="pubmed">10050719</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF HAEMATOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>multiple myeloma</api:keyword><api:keyword>interleukin-1 beta</api:keyword><api:keyword>tumour necrosis factor-alpha</api:keyword><api:keyword>monoclonal gammopathy of undetermined significance</api:keyword><api:keyword>immunoglobulin light chain</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>350</api:begin-page><api:end-page>357</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of interleukin-1β and tumour necrosis factor-α in plasma cells from patients with multiple myeloma</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" id="22187" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000078676100022" last-modified-when="2014-07-25T11:00:28.153+01:00"><api:citation-count>47</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sati</api:last-name><api:initials>HIA</api:initials><api:first-names>HIA</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>I</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Greaves</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>RGG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRIT J HAEMATOL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>multiple myeloma</api:keyword><api:keyword>interleukin-1 beta</api:keyword><api:keyword>tumour necrosis factor-alpha</api:keyword><api:keyword>monoclonal gammopathy of undetermined significance</api:keyword><api:keyword>immunoglobulin light chain</api:keyword><api:keyword>BONE-RESORBING CYTOKINE</api:keyword><api:keyword>MARROW CELLS</api:keyword><api:keyword>SECRETION</api:keyword><api:keyword>GROWTH</api:keyword><api:keyword>LYMPHOTOXIN</api:keyword><api:keyword>RESORPTION</api:keyword><api:keyword>INVITRO</api:keyword><api:keyword>LINES</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>350</api:begin-page><api:end-page>357</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of interleukin-1 beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Fluorescent Antibody Technique</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interleukin-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Paraproteinemias</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Plasma Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">RNA, Messenger</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Plasma Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Paraproteinemias</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">RNA, Messenger</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interleukin-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Fluorescent Antibody Technique</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3201 Cardiovascular Medicine and Haematology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Hematology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Rare Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Fluorescent Antibody Technique</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interleukin-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Paraproteinemias</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Plasma Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">RNA, Messenger</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Necrosis Factor-alpha</api:keyword><api:keyword origin="record-data" source="wos-lite">multiple myeloma</api:keyword><api:keyword origin="record-data" source="wos-lite">interleukin-1 beta</api:keyword><api:keyword origin="record-data" source="wos-lite">tumour necrosis factor-alpha</api:keyword><api:keyword origin="record-data" source="wos-lite">monoclonal gammopathy of undetermined significance</api:keyword><api:keyword origin="record-data" source="wos-lite">immunoglobulin light chain</api:keyword><api:keyword origin="record-data" source="wos">multiple myeloma</api:keyword><api:keyword origin="record-data" source="wos">interleukin-1 beta</api:keyword><api:keyword origin="record-data" source="wos">tumour necrosis factor-alpha</api:keyword><api:keyword origin="record-data" source="wos">monoclonal gammopathy of undetermined significance</api:keyword><api:keyword origin="record-data" source="wos">immunoglobulin light chain</api:keyword><api:keyword origin="record-data" source="wos">BONE-RESORBING CYTOKINE</api:keyword><api:keyword origin="record-data" source="wos">MARROW CELLS</api:keyword><api:keyword origin="record-data" source="wos">SECRETION</api:keyword><api:keyword origin="record-data" source="wos">GROWTH</api:keyword><api:keyword origin="record-data" source="wos">LYMPHOTOXIN</api:keyword><api:keyword origin="record-data" source="wos">RESORPTION</api:keyword><api:keyword origin="record-data" source="wos">INVITRO</api:keyword><api:keyword origin="record-data" source="wos">LINES</api:keyword><api:keyword scheme="for" origin="issn-inferred">1102 Cardiorespiratory Medicine and Haematology</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Immunology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3201 Cardiovascular medicine and haematology</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-1048" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665" title="British Journal of Haematology"><api:records><api:record source-name="summary"><api:title>British Journal of Haematology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/70/relationships"/></api:object></api:result></api:response>